Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Miyazato, Yusuke ; Yamamoto, Kei ; Yamada, Gen ; Kubota, Shuji ; Ishikane, Masahiro ; Sugiyama, Masaya ; Ueno, Mikako ; Matsunaga, Akihiro ; Miyoshi-Akiyama, Tohru ; Ishizaka, Yukihito ; Ohmagari, Norio
  More +
• Description:
  A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem inflammatory syndrome. COVID-19 vaccination could be a trigger for this condition.
• Subjects:
  • Adult
  • Covid-19 Vaccines
  • Humans
  • Male
  • Vaccines, Synthetic
  • Mrna Vaccines
• Source:
  Emerg Infect Dis. 2022; 28(4):870-872
• Pubmed ID:
  35148495
• Pubmed Central ID:
  PMC8962876
• Document Type:
  Journal Article
• Funding:
  21A006/ImNIH/Intramural NIH HHSUnited States/
• Genre:
  Letter
• Place as Subject:
  Japan
• Volume:
  28
• Issue:
  4
• Download URL:
  https://stacks.cdc.gov/view/cdc/116348/cdc_116348_DS1.pdf
• File Type:
  [PDF - 670.17 KB]
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:02c75b34a583d140f10bd3ead3324b119f7b83ffaaccd6f752884dc156180eb0